Jody Folloder

614 total citations
10 papers, 450 citations indexed

About

Jody Folloder is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Jody Folloder has authored 10 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Jody Folloder's work include Hematopoietic Stem Cell Transplantation (5 papers), Immune Cell Function and Interaction (3 papers) and Platelet Disorders and Treatments (2 papers). Jody Folloder is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Immune Cell Function and Interaction (3 papers) and Platelet Disorders and Treatments (2 papers). Jody Folloder collaborates with scholars based in United States and United Kingdom. Jody Folloder's co-authors include Paolo Anderlini, Richard E. Champlin, Donna Przepiorka, Terry L. Smith, Martin Körbling, Saroj Vadhan‐Raj, Sergio Giralt, David F. Claxton, Naoto T. Ueno and Ira Braunschweig and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Jody Folloder

10 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jody Folloder United States 9 310 162 121 57 47 10 450
Mary Horowitz United States 9 309 1.0× 194 1.2× 149 1.2× 78 1.4× 26 0.6× 17 458
SJ Forman United States 8 413 1.3× 100 0.6× 116 1.0× 70 1.2× 33 0.7× 8 517
S. Giralt United States 5 325 1.0× 95 0.6× 218 1.8× 47 0.8× 23 0.5× 18 486
MR Litzow United States 14 517 1.7× 113 0.7× 260 2.1× 78 1.4× 52 1.1× 14 631
A Rosenmayr Austria 10 374 1.2× 256 1.6× 97 0.8× 62 1.1× 24 0.5× 20 522
Laura Bellio Italy 10 203 0.7× 142 0.9× 186 1.5× 82 1.4× 32 0.7× 15 508
DE Stepan United States 7 314 1.0× 113 0.7× 145 1.2× 93 1.6× 37 0.8× 9 503
Giuseppe Console Italy 15 475 1.5× 90 0.6× 302 2.5× 87 1.5× 36 0.8× 51 633
Gabrielle Meyers United States 15 334 1.1× 174 1.1× 124 1.0× 169 3.0× 59 1.3× 43 602
Edward Peres United States 10 337 1.1× 165 1.0× 127 1.0× 159 2.8× 31 0.7× 39 554

Countries citing papers authored by Jody Folloder

Since Specialization
Citations

This map shows the geographic impact of Jody Folloder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jody Folloder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jody Folloder more than expected).

Fields of papers citing papers by Jody Folloder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jody Folloder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jody Folloder. The network helps show where Jody Folloder may publish in the future.

Co-authorship network of co-authors of Jody Folloder

This figure shows the co-authorship network connecting the top 25 collaborators of Jody Folloder. A scholar is included among the top collaborators of Jody Folloder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jody Folloder. Jody Folloder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ramondetta, Lois M., Charlotte C. Sun, Lisa M. Hollier, et al.. (2006). Advanced cervical cancer treatment in Harris County: Pilot evaluation of factors that prevent optimal therapy. Gynecologic Oncology. 103(2). 547–553. 11 indexed citations
2.
Folloder, Jody. (2005). Effects of Darbepoetin Alfa Administered Every Two Weeks on Hemoglobin and Quality of Life of Patients Receiving Chemotherapy. Oncology nursing forum. 32(1). 81–91. 2 indexed citations
3.
Vadhan‐Raj, Saroj, Shreyaskumar Patel, Carlos Bueso-Ramos, et al.. (2003). Importance of Predosing of Recombinant Human Thrombopoietin to Reduce Chemotherapy-Induced Early Thrombocytopenia. Journal of Clinical Oncology. 21(16). 3158–3167. 49 indexed citations
4.
Freedman, Ralph S., Saroj Vadhan‐Raj, Cherié Butts, et al.. (2003). Pilot study of Flt3 ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas.. PubMed. 9(14). 5228–37. 55 indexed citations
6.
Przepiorka, Donna, Terry L. Smith, Jody Folloder, et al.. (2001). Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen–matched related donors. Blood. 97(11). 3405–3410. 40 indexed citations
7.
Saliba, Rima M., Karen R. Cleary, Harald E. Fischer, et al.. (2000). Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1. Biology of Blood and Marrow Transplantation. 6(2). 190–197. 17 indexed citations
8.
Przepiorka, Donna, Koen van Besien, Brian L. Samuels, et al.. (1999). Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma. Annals of Oncology. 10(5). 527–529. 38 indexed citations
9.
Przepiorka, Donna, Terry L. Smith, Jody Folloder, et al.. (1999). Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Blood Stem Cell Transplantation. Blood. 94(4). 1465–1470. 170 indexed citations
10.
Przepiorka, Donna, Terry L. Smith, Jody Folloder, et al.. (1999). Risk Factors for Acute Graft-Versus-Host Disease After Allogeneic Blood Stem Cell Transplantation. Blood. 94(4). 1465–1470. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026